Wow, I just found this, a little off topic, but if true, disgraceful. No reason

[Guest guest]

to doubt, comes from the Wall Street Journal

http://www.karlloren.com/healthinsurance/p43.htm

The U.S. biotech giant Genentech Inc. and Swiss drug maker Novartis AG

insisted that Tanox kill TNX-901 in favor of a Genentech drug called

Xolair that has yet to prove effective against peanut allergy. When

Tanox refused, its partners took it to court. The ensuing legal fight

to kill TNX-901 spanned five years and consumed well over $100 million

in legal fees.